Influence of a functional polymorphism within the angiotensin I-converting enzyme gene on partial sleep deprivation in patients with major depression

Neuroscience Letters

Volumn 339, Issue 3, 2003, Pages 223-226

  Baghai, Thomas C ^a   Schule, Cornelius ^a   Zwanzger, Peter ^a   Zill, Peter ^a   Ella, Robin ^a   Eser, Daniela ^a   Deiml, Tobias ^a   Minov, Christo ^a   Rupprecht, Rainer ^a   Bondy, Brigitta ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

Affective disorders; Angiotensin I converting enzyme; Antidepressive therapy; Insertion deletion polymorphism; Major depression; Sleep deprivation

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; GENOMIC DNA;

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; DISEASE EXACERBATION; DNA POLYMORPHISM; DOPAMINERGIC TRANSMISSION; FEMALE; GENE DELETION; GENE INSERTION; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RATING SCALE; RELAPSE; SLEEP DEPRIVATION; TREATMENT OUTCOME;

EID: 0037468582     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(03)00026-0     Document Type: Article

References (22)

1. Baghai T.C., Schule C., Zwanzger P., Minov C., Schwarz M.J., de Jonge S., Rupprecht R., Bondy B. Possible influence of the insertion/deletion polymorphism in the angiotensin I-converting enzyme gene on therapeutic outcome in affective disorders. Mol. Psychiatry. 6:2001;258-259.
2. Baghai T.C., Schule C., Zwanzger P., Minov C., Zill P., Ella R., Eser D., Oezer S., Bondy B., Rupprecht R. Hypothalamic-pituitary-adrenocortical axis dysregulation in patients with major depression is influenced by the insertion/deletion polymorphism in the angiotensin I-converting enzyme gene. Neurosci. Lett. 328:2002;299-303.
3. Bech P., Gram L.F., Dein E., Jacobsen O., Vitger J., Bolwig T.G. Quantitative rating of depressive states. Acta Psychiatr. Scand. 51:1975;161-170.
4. Benedetti F., Barbini B., Campori E., Colombo C., Smeraldi E. Dopamine agonist amineptine prevents the antidepressant effect of sleep deprivation. Psychiatry Res. 65:1996;179-184.
5. Benedetti F., Serretti A., Colombo C., Campori E., Barbini B., di Bella D., Smeraldi E. Influence of a functional polymorphism within the promoter of the serotonin transporter gene on the effects of total sleep deprivation in bipolar depression. Am. J. Psychiatry. 156:1999;1450-1452.
6. Ebert D., Berger M. Neurobiological similarities in antidepressant sleep deprivation and psychostimulant use: a psychostimulant theory of antidepressant sleep deprivation. Psychopharmacology. 140:1998;1-10.
7. Jenkins T.A., Allen A.M., Chai S.Y., Mendelsohn F.A. Interactions of angiotensin II with central catecholamines. Clin. Exp. Hypertens. 17:1995;267-280.
8. Jeunemaitre X. Genetic polymorphisms in the renin-angiotensin system. Therapie. 53:1998;271-277.
9. Jezova D., Ochedalski T., Kiss A., Aguilera G. Brain angiotensin II modulates sympathoadrenal and hypothalamic pituitary adrenocortical activation during stress. J. Neuroendocrinol. 10:1998;67-72.
10. Kramer M.S., Cutler N., Feighner J., Shrivastava R., Carman J., Sramek J.J., Reines S.A., Liu G., Snavely D., Wyatt-Knowles E., Hale J.J., Mills S.G., MacCoss M., Swain C.J., Harrison T., Hill R.G., Hefti F., Scolnick E.M., Cascieri M.A., Chicchi G.G., Sadowski S., Williams A.R., Hewson L., Smith D., Rupniak N.M. Distinct mechanism for antidepressant activity by blockade of central substance P receptors. Science. 281:1998;1640-1645.
11. Mendelsohn F.A., Jenkins T.A., Berkovic S.F. Effects of angiotensin II on dopamine and serotonin turnover in the striatum of conscious rats. Brain Res. 613:1993;221-229.
12. Nutt D. Substance-P antagonists: a new treatment for depression? Lancet. 352:1998;1644-1646.
13. Oehme P., Hecht K., Piesche L., Hilse H., Rathsack R. Relation of substance P to stress and catecholamine metabolism. Ciba Found. Symp. 91:1982;296-306.
14. Piesche L., Oehme P., Hilse H., Hecht K. Effect of substance P on dopamine-beta-hydroxylase and phenethanolamine-N-methyltransferase in the adrenal glands of rats. Pharmazie. 37:1982;591-593.
15. Reardon K.A., Mendelsohn F.A., Chai S.Y., Horne M.K. The angiotensin converting enzyme (ACE) inhibitor, perindopril, modifies the clinical features of Parkinson's disease. Aust. New Zealand J. Med. 30:2000;48-53.
16. Rigat B., Hubert C., Alhenc-Gelas F., Cambien F., Corvol P., Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J. Clin. Invest. 86:1990;1343-1346.
17. Schilgen B., Tolle R. Partial sleep deprivation as therapy for depression. Arch. Gen. Psychiatry. 37:1980;267-271.
18. Schumann G., Benedetti F., Voderholzer U., Kammerer N., Hemmeter U., Travers H.W., Fiebich B., Holsboer-Trachsler E., Berger M., Seifritz E., Ebert D. Antidepressive response to sleep deprivation in unipolar depression is not associated with dopamine D3 receptor genotype. Neuropsychobiology. 43:2001;127-130.
19. Serretti A., Benedetti F., Colombo C., Lilli R., Lorenzi C., Smeraldi E. Dopamine receptor D4 is not associated with antidepressant activity of sleep deprivation. Psychiatry Res. 89:1999;107-114.
20. Shirayama Y., Mitsushio H., Takashima M., Ichikawa H., Takahashi K. Reduction of substance P after chronic antidepressants treatment in the striatum, substantia nigra and amygdala of the rat. Brain Res. 739:1996;70-78.
21. Skidgel R.A., Erdos E.G. The broad substrate specificity of human angiotensin I converting enzyme. Clin. Exp. Hypertens. A. 9:1987;243-259.
22. Wu J.C., Bunney W.E. The biological basis of an antidepressant response to sleep deprivation and relapse: review and hypothesis. Am. J. Psychiatry. 147:1990;14-21.